PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 57: Articles 28001-28500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Benign hepatic neoplasia and intra-abdominal hemorrhage following oral contraceptives. [Gutartige Leberzelltumoren und intraabdominelle Haemorrhag ie nach Einnahme oraler Kontrazeptiva.]
  2. Benign liver tumors and oral contraceptives.
  3. Benign liver tumors and oral contraceptives. [Benigne Lebertumoren und orale Kontrazeptiva.]
  4. Benign tumors of liver and oral contraception. [Tumeurs benignes du foie et contraceptifs oraux.]
  5. Beyond family planning.
  6. Bile calculi and oral contraceptive drugs (author's transl) [Lithiase biliare et contraceptifs oraux.]
  7. Biochemical change in uterine fluid after insertion of various types of intra-uterine contraceptive device.
  8. Birth Control and reproductive health services for men.
  9. Birth control education in Michigan's schools: elements of a successful 10-year effort.
  10. Birth control in nineteenth-century England.
  11. Birth control in Tunisia. [La regulation des naissances en Tunisie.]
  12. Birth control in young females. [Geburtenregelung bei jungen Frauen.]
  13. Birth control practices and levels of development in India.
  14. Birth control revisited.
  15. Birth control slows in India; targets put back by years.
  16. Birth control vaccine trials launched.
  17. Birth control: the role of behavioral methods. [Il controllo delle nascite: spazio attuale dei metodi naturali.]
  18. Birth planning success: motivation and contraceptive method.
  19. Birth rate and birth control in Sweden 1962-1976 (author's transl) [Nativitet och foedeksekontroll i Sverige 1962-1976.]
  20. Birth rates and birth control practice: relations based on the computer models TABRAP and CONVERSE.
  21. Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women using d-norgestrel subdermal polysiloxane capsules for contraception.
  22. Bleeding hepatic adenoma and its relation to oral contraceptives. [Adenoma hepatico sangrante y su relacion con los anovulatorios.]
  23. Blood glucose and serum triglyceride levels in "normal" women using intrauterine contraceptive device.
  24. Blood glucose, insulin, cholesterol and triglyceride levels in women treated for six months with the weekly contraceptive R2323.
  25. Blood lipids during treatment with oral contraceptives. [Lipidemia in corso di trattamento con anticoncezional orali.]
  26. The blood pressure effects of oral contraceptives.
  27. Brazil's changing family planning policy: a first step??
  28. Brief report on status of integrated family planning and parasite control project, Nepal.
  29. The broader aspects of family planning. (Editorial)
  30. Budd-Chiari syndrome: inductive role of oral contraceptives? [Syndrome de Budd-Chiari: role favorisant des contraceptifs oraux?]
  31. Campaign for natural birth control methods.
  32. A campaign for revival (of India's family planning programme)
  33. Campaigning for choice: a review of the role of media-based publicity in promoting contraception.
  34. Carbohydrate and lipid metabolism in women using the Progestasert intrauterine progesterone contraceptive system.
  35. Cardiovascular complications of oral contraceptives.
  36. Cardiovascular disease and non-contraceptive oestrogen therapy.
  37. Cardiovascular effects of oral contraceptives.
  38. Case study Kenya (in population/family planning). (Statement, April 26, 1978)
  39. A Catholic hospital and natural family planning.
  40. CBFPS (Community-based Family Planning Services) in Thailand: a community-based approach to family planning.
  41. CBFPS in Thailand: a community-based approach to family planning.
  42. Cellular actions of estrogens and oral contraceptive sex steroid hormones.
  43. Central retinal vascular occlusion associated with oral contraceptives.
  44. Cerebral pseudotumor and oral contraceptives: clinical case. [Pseudotumor cerebri e contraccettivi orali: caso clinico.]
  45. Cervical mucus: a new dimension for family planning.
  46. CFSC (Community and Family Study Center) study finds birth rates falling everywhere - family planning (family planning) is a factor.
  47. The challenge to contraceptive research.
  48. Changes in carbohydrate metabolism brought about by combined oral contraceptives. [Variations du metabolisme hydrocarbone provoquees par les contraceptifs oraux combines.]
  49. Changes in laboratory tests treatment with a new contraceptive agent. [Alteraciones en las pruebas de laboratorio despues de tratamiento con un nuevo anovulatorio.]
  50. Changes in sexual behavior among unmarried teenage women utilizing oral contraception.
  51. Changes in the endometrium from the use of hormonal preparations and hormonal contraceptives. [Izmenenya v endometrii pri ispolzovanii ghormonalnykh preparatov i ghormonalnikh contratseptivov.]
  52. Changing of individual attitudes and values in population and family planning: human roles versus traditional sex roles.
  53. The characteristics of a levonorgestrel/estradiol releasing contraceptive vaginal ring. [Abstract]
  54. Characteristics of the family planning program users, 1977. [Caracteristicas de las usuarias del programa de planificacion familiar, 1977.]
  55. Characteristics of vasectomy patients at a family planning clinic.
  56. Chile: child allowances do not discourage contraceptive use.
  57. Choice of contraceptive method in teenage girls. (Letter)
  58. Choice of contraceptive pill. [Valg av P-pille.]
  59. Choice of oral contraceptives for a large family planning program.
  60. The choice of the dose of oestrogen in a combined oral contraceptive.
  61. Cholestatic jaundice following triacetyloleandomycine-interaction with oral contraceptives-ten cases. [Ictere cholestatique survenu apres administration de triacetyloleandomycine: interference avec les contraceptifs oraux? Dix observations.]
  62. Choosing the appropriate oral contraceptive.
  63. Chorea complicating oral contraceptive therapy: case report and review of the literature.
  64. The Church and birth control: a positive attitude.
  65. Classical approaches to population and family planning.
  66. Clinical analysis and evaluation of some hematologic and metabolic constants in the use of monthly microdose contraceptive injections. [Analisis clinico y valoracion de algunas constantes hematologicas y metabolicas en el uso de un anticonceptivo parenteral mensual en microdosis.]
  67. A clinical and angiographic study of occlusions of the posterior cerebral artery with special reference to the pathenogenic role of oral contraceptives and nicotine abuse (author's transl) [Verschluesse der A. cerebri posterior unter besonderer Beruecksichtigung des Nikotinabusus und der hormonalen Antikonzeptiva: Eine klinische und angiographische Studie.]
  68. Clinical applications in the area of contraceptive development.
  69. Clinical aspects of a new low-dose combined oral contraceptive. [Klinische Aspekte eines neuen, sehr niedrig dosierten Kontrazeptivums vom Kombinationstyp.]
  70. Clinical aspects of contraception by means of Copper-7 and Copper-T intrauterine devices. [Kliuniczne aspekty antykoncepcji przy pomocy wkladek wenatrzmacicznych Copper-u i Copper-T.]
  71. Clinical experience of Copper-T intrauterine contraceptive device. (Author's transl)
  72. Clinical experience with a low dose oral contraceptive containing norethisterone and ethinyl oestradiol.
  73. Clinical experience with implant contraception.
  74. Clinical experience with the intrauterine progesterone contraceptive system.
  75. Clinical experience with the Progestasert intrauterine progesterone contraceptive system in Asia.
  76. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel.
  77. Clinical results in Latin America with the intrauterine progesterone contraceptive system.
  78. Clinical trials with injectable contraceptives.
  79. The clinical, radiologic, and pathologic characterization of benign hepatic neoplasms: alleged association with oral contraceptives.
  80. Closing down family planning clinics. (Letter)
  81. Collagen sponge may provide barrier contraception.
  82. Combination depot estrogen-progestin contraceptive method.
  83. Combination of gestagen and androgen as a male contraceptive.
  84. Combined oral contraceptives.
  85. Comment...(Difficulties found by teenagers seeking birth control advice.)
  86. A commentary on "A survey evaluation of the efficacy and efficiency of natural family planning services and methods in Australia" -- The Sydney Survey.
  87. Commercial contraceptive marketing development in Bangladesh. Annual report.
  88. Commercial distribution of contraceptives in Sri Lanka: the Preethi experience.
  89. The commercial distribution of contraceptives program in Jamaica.
  90. Communicating family planning to rural Guatemala.
  91. A communication experiment to increase the demand for voluntary surgical contraception in El Salvador.
  92. Communication principles in family planning.
  93. Communications for social marketing: a study in family planning.
  94. Community Health and Family Planning Project of the Christian Medical Association of India, Bangalore: a bird's eye view, 1977.
  95. The community-based channels for the diffusion of family planning.
  96. Community-based distribution of contraceptives.
  97. Community-based family planning programs: concepts and problems. [Programas de planificacion familiar con base comunitaria: conceptos y problemas.]
  98. Comparative costs of the various family planning programs of profamilia. [Costo comparativo de los diferentes programas de planificacion familiar de Profamilia.]
  99. Comparative electron microscopic studies of benign hepatoma and icterus in patients on oral contraceptives.
  100. Comparative evaluation of family planning programs in selected countries of East and Southeast Asia.
  101. Comparative studies of the ethynyl estrogens used in oral contraceptives. 6. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles.
  102. Comparative studies of the ethynyl estrogens used in oral contraceptives. 7. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in human.
  103. Comparative studies of the ethynyl estrogens used in oral contraceptives: effects with and without progestational agents on plasma androstenedione, testosterone, and testosterone binding in humans, baboons, and beagles.
  104. Comparative studies on two combination oral contraceptives, one containing synthetic estrogen, the other "natural" estrogens.
  105. A comparative study of health status of children whose parents have undergone family planning operations with those whose parents were not.
  106. A comparative study of immunisation status of children whose parents had undergone family planning operations with those whose parents were not.
  107. A comparative study on the input-output relationships of family planning programmes in selected countries of the ESCAP region.
  108. Comparative vaginal cytology in testing gestagen components of 2 contraceptive preparations. [Vergleichende vaginalzytologische Prufung der gestagenkomponenten zweier Kombinationspraparate.]
  109. Comparison of plasma hormone changes using a "conventional" and a "paper" pill formulation of a low-dose oral contraceptive.
  110. Comparison of spontaneous and contraceptive menstrual cycles on a visual discrimination task.
  111. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
  112. Comparison of the effects on circulating hormone levels of a conventional and a paper pill oral contraceptive.
  113. Complications of the new contraceptive preparations.
  114. A components method for measuring the impact of a family planning program on birth rates.
  115. Contraception in Latin America: the need for improved contraceptive technology.
  116. Contraception in the adolescent.
  117. Contraception in the adolescent: adolescent sexuality: legal aspects.
  118. Contraception in the adolescent: alternative methods.
  119. Contraception in the adolescent: educational programmes.
  120. Contraception in the adolescent: introduction.
  121. Contraception in the adolescent: psychological aspects.
  122. Contraception in the adolescent: sexually-transmitted diseases.
  123. Contraception in the adolescent: steps towards a situational ethic.
  124. Contraceptive status in a community attached to a hospital in Delhi.
  125. Contraceptive sterilization as a grassroots response: a comparative view of the Puerto Rican and United States experience.
  126. Contraceptive sterilization in the United States. (Statement, February 21, 1978)
  127. Contraceptive steroids and breast cancer.
  128. Contraceptive steroids and breast cancer. (Letter)
  129. Contraceptive steroids increase melanoma risk?
  130. Contraceptive technology: coming into its own??
  131. Contraceptive use in Jamaica: the social, economic and cultural context.
  132. Contraceptive use in rural Nicaragua.
  133. Contraceptive use in the United States. 1973-1976.
  134. Contraceptive use.
  135. Contraceptive use: youth. [Prevensjonsbruk: ungdom.]
  136. Contraceptive utilization among widowed, divorced, and separated women in the United States: 1973 and 1976.
  137. Contraceptive utilization in the United States: 1973 and 1976.
  138. Contraceptives and birth control: a bibliography with abstracts. (Search period covered 1964-November 1978))
  139. Contraceptives and the young: present status and future prospects.
  140. Contraceptives for women in their forties? [Ovulationshemmer bei der Frau um 40?]
  141. Contraceptives.
  142. The contribution of nurse practitioners to service delivery in family planning.
  143. Control of contraceptives: patient labelling for oral contraceptives - United States of America.
  144. A controlled study of the effect of oral contraceptives on migraine.
  145. Coordination in the implementation of family planning programs.
  146. Copper intrauterine contraceptive devices in adolescent nulliparae.
  147. Correlates of contraceptive behavior among unmarried U.S. college students.
  148. Depo-Provera (injectable contraceptive): a review.
  149. (Depo-Provera and its current and possible future relationship to A.I.D.'s population and family planning activities.) (Statement, August 10, 1978.))
  150. Depo-provera injectable contraceptive as fertility control technique through hospitals and dispensaries affiliated to Christian Health Care Project.
  151. Depo-Provera: just another contraceptive?
  152. Depression and oral contraceptives: the role of pyridoxine.
  153. Depressive type disorders in women taking oral contraceptives: a psychometric study. [Disturbi di tipo depressivo in corso di assunzione di contraccettivi orali: una indagine psicometrica.]
  154. The determination of antithrombin 111: comparison of six methods: effect of oral contraceptive therapy.
  155. Developing a clinic strategy appropriate to community family planning needs and practices: an experience in Lagos, Nigeria.
  156. Development and production of family planning materials: a state of the art. - Experiences of selected agencies engaged in population and population-related activities.
  157. Development of bio-erodable contraceptive implants.
  158. Development of commercial contraceptive marketing in Ghana. Annual report.
  159. Development of commercial contraceptive marketing in Ghana. Semi-annual report.
  160. Development of commercial contraceptive marketing in Nepal.
  161. The development of family planning in Japan with industrial involvement.
  162. Development of intrauterine contraceptives.
  163. Development of the oral contraceptives.
  164. Developments in family planning overseas: sharing co-operation and communication: the lesson of Hong Kong. Part two of an account of programmes in Britain, Italy, Singapore, Hong Kong, and Malaysia.
  165. DHEW proposes 30-day waiting period for sterilizations; no funds for under 21s, contraceptive hysterectomies.
  166. Differences between physicians and nurses in providing family planning services: findings from a Bogota clinic.
  167. Discuss family planning before discharging mother postpartum.
  168. Discussion (on current concepts of contraception)
  169. Discussion 1: (intrauterine progesterone and Progestasert for contraception)
  170. Discussion of risks for women taking oral contraceptives in different age groups.
  171. Discussion of which women on oral contraceptives are going to be at risk.
  172. Discussion summary (of steroid contraception as a carcinogenic agent)
  173. Discussion summary (of steroid contraception: metabolic and endocrine effects)
  174. Discussion summary (of the need for improved contraceptive technology)
  175. Distribution - on or off prescription (of oral contraceptives)?

     

  176. Do drugs and antibiotics affect hormonal contraception? [Beeinflussen Chemotherapeutika und Antibiotika die hormonale Kontrazeption?]
  177. Do oral contraceptives cause hepatic lesions? Appraising the evidence.
  178. Does teenage pregnancy jeopardize later births? (Paper presented at the 16th Annual Meeting of the Association of Planned Parenthood Physicians, San Diego, California, October 25-27, 1978)
  179. Domiciliary family planning.
  180. Dropping out: family planning discontinuation in Kenya.
  181. Drug interaction with oral contraceptives.
  182. Drug interactions with oral contraceptives.
  183. Drug interactions with oral contraceptives.
  184. Drug surveillance by case-control methods as means for detecting side-effects of oral contraceptives.
  185. Economics versus racial discrimination in the provision of birth-control services in the United States.
  186. Ectopic pregnancy and the intrauterine contraceptive device.
  187. Ectopic pregnancy: relationship to the preceding contraception.
  188. Education and contraceptive choice: conditional logit and structural models.
  189. Education in health and family planning to nurses and midwives. [L'enseignement de la sante et de la planification familiales aux infirmieres et aux sage femmes.]
  190. Education, not religion, factor in the birth control use by Moslem women.
  191. Effect of a low-dose oral contraceptive (150 mcg Levonorgestrel and 30 mcg Ethinylestradiol) on lactation.
  192. The effect of contraceptive steroids on the immune response to prophylactic antigens.
  193. The effect of environment on tryptophan metabolism via kynurenine in oral contraceptive users.
  194. Effect of family planning program on reduction in fertility in Haryana, 1965-75.
  195. The effect of family planning programs on fertility decline in four Asian countries.
  196. Effect of injectable contraceptives Depo-Provera and norethisterone oenanthate on pituitary gonadotropin response to Luteinizing hormone-releasing hormone.
  197. Effect of medroxyprogesterone acetate contraception on cytoplasmic estrogen receptor content of the human cervix uteri.
  198. Effect of oral alanine loads on plasma amino acids in oral contraceptive users and control women.
  199. The effect of oral contraceptive on serum immunoglobulins.
  200. Effect of oral contraceptive steroids on Vitamin A status of women and female rats.
  201. Effect of oral contraceptive therapy on gingival inflammation in humans.
  202. The effect of oral contraceptive treatment on the serum concentration of dehydroisoandrosterone sulfate.
  203. Effect of oral contraceptive use on the risk of human breast and cervical cancer.
  204. Effect of oral contraceptives on human metabolism.
  205. The effect of oral contraceptives on micronutrients.
  206. The effect of oral contraceptives on mononuclear cell cholesterol ester hydrolase activity in premenopausal women taking oral contraceptives: relevance to atherosclerosis.
  207. The effect of oral contraceptives on nutritional status and metabolism of the Asian woman (Sri Lanka)
  208. Effect of oral contraceptives on plasma androgenic steroids and their precursors.
  209. Effect of oral contraceptives on tear production.
  210. Effect of oral contraceptives on the capacity to stimulate plasma renin activity and plasma aldosterone. [Einfluss oraler Kontrazeptiva auf die Stimulierbarkeit der Plasmarenin-Aktivitaet und des Plasma-Aldosterons.]
  211. The effect of oral contraceptives on the gonadotropin response to LHRH.
  212. The effect of pregnancy and 2 different contraceptive pills on serum lipids and lipoproteins in a woman with a type III hyperlipoproteinaemia pattern.
  213. Effect of pregnancy on liver tumor associated with oral contraceptives.
  214. Effect of the menstrual cycle, oral contraception and pregnancy on forearm blood flow, venous distensibility and clotting factors.
  215. Effectiveness of nurses in contraceptive services.
  216. The effects of a once-a-week steroid contraceptive (R2323) on lipid and carbohydrate metabolism in women during three months of use.
  217. Effects of an oral contraceptive on hepatic size and antipyrine metabolism in premenopausal women.
  218. The effects of breastfeeding, temporary emigration, and contraceptive use on the fertility of the Yemen Arab Republic.
  219. Effects of cigarette smoke and oral contraceptives on plasma and whole-blood viscosity: rheological investigations in healthy persons. [Auswirkungen von Zigarettenrauch und oralen Kontrazeptiva auf die Plasma-und Vollblutviskositaet: Rheologische Untersuchungen an Gesunden.]
  220. Effects of contraceptive pills in field of otolaryngology (author's transl) [Auswirkungen von steroidaler Kontrazeption auf Organe im HNO-Bereich?]
  221. Effects of contraceptives on glycemia and insulinemis. [Efecto de los anticonceptivos sobre la glicemia e insulinemia.]
  222. The effects of husband and wife education on family planning in rural Turkey.
  223. The effects of long-term usage of oral contraceptive steroid drugs on vitamin A, beta carotene, ascorbic acid, riboflavin and niacin in women. (Abstract only.)
  224. Effects of low-oestrogen oral contraceptives. (Letter)
  225. Effects of oral contraceptives on cancerogenesis of cervical epithelium (author transl) [Einfluss oraler Ovulationshemmer auf die Kanzerogenese des Zervixepithels.]
  226. Effects of oral contraceptives on psyche and sexuality. [Einfluss oraler Kontrazeptiva auf Psyche und Sexualitat.]
  227. Effects of oral contraceptives on zinc and copper levels in human plasma and endometrium during the menstrual cycle.
  228. Effects of program contraception on fertility: a comparison of three Asian countries.
  229. Effects of various factors on selection for family planning status and natural fecundability: a simulation study.
  230. The effects on sexual response and mood after sterilization of women taking long-term oral contraception: results of a double-blind cross-over study.
  231. Efficacy is over-the-counter contraceptives issue.
  232. Efficacy of three-phase oral contraceptives.
  233. Eighteen months contraception following subdermal insertion of silastic capsules containing norgestrienone.
  234. Elective surgery and the contraceptive pill.
  235. Electronmicroscopic findings in a malignant hepatoma after oral contraceptives (author's transl) [Elektronenmikroskopische Befunde eines malignen Hepatoms nach oraler Kontrazeption.]
  236. Endocrine approach to male contraception (5th Annual Workshop on the Testis, Geilo, Norway, April 1978)
  237. Endocrinologic aspects of oral contraception.
  238. Endogenous antispermatogenic agents: prospects for male contraception.
  239. Endometrial histology and progesterone levels in women using norethindrone acetate implants for contraception.
  240. Endometrial morphology of women wearing an intrauterine progesterone contraceptive system.
  241. Epidemiological study of oral contraceptive use and stroke among childbearing age women in Taiwan: prevalence of pill use and stroke mortality rates.
  242. Epithelial atypias associated with intrauterine contraceptive devices (IUD)
  243. Erroneous clinical diagnosis of leg vein thrombosis in women on oral contraceptives.
  244. Erythema nodosum and oral contraceptive therapy.
  245. Erythrocyte membrane (Na+, K+) and (Mg++, Ca++) activated adenosine triphosphatases in women using oral contraceptives - a preliminary report.
  246. Estimating the effects of contraceptive use on fertility: techniques and findings from the 1974 Philippine National Acceptor Survey.
  247. Estimation of family planning program impact on fertility decline in Colombia with the TABRAP/CONVERSE model. [Estimacion del impacto de los programas de planificacion familiar en la disminucion de la fecundidad en Colombia con el modelo TABRAP/CONVERSE.]
  248. Estrogen and progestin therapy for reasons other than contraception.
  249. Estrogen and progestogen binding site concentrations in human endometrium and cervix throughout the menstrual cycle and in tissue from women taking oral contraceptives.
  250. Europe without myths: socio-economic factors relating to family planning.
  251. Evaluation of a combined oestrogen-progestogen injectable contraceptive.
  252. Evaluation of an estrogen-progestagen combination in reduced doses with contraceptive purpose. [Valoracion de una asiciacion estrogeno progestageno en dosis reducidas con fines anticonceptivos.]
  253. An evaluation of community based distribution (CBD) programmes of the International Planned Parenthood Federation.
  254. Evaluation of family planning programs. [Evaluacion en programas de planificacion familiar.]
  255. An evaluation of male contraceptive acceptance in rural Ghana.
  256. Evaluation of modern contraception. [Eine Wertung der modernen Kontrazeption.]
  257. Evaluation of testosterone enanthate (TE) as a male contraceptive. (Abstract only)
  258. An evaluation of the commercial distribution of contraceptives program in Nepal.
  259. An evaluation of the retail contraceptive sales program Ghana- AID/pha/C-1145.
  260. Evaluation of various liver functions and blood coagulation tests in early stages of treatment with oral contraceptives. [Valutazione di alcuni parametri epatofunzionali ed emocoalulativi in fasi precoci di trattamento con contraccettivi orali.]
  261. Evaluation report on the contraceptive prevalence studies project.
  262. Evaluation: maternal and child health/family planning annual report: Kenya, 1977.
  263. Every child a wanted child. Clarence James Gamble, M.D. and his work in the birth control movement.
  264. The examination of a woman requesting oral contraception. [Examen prealable d'une femme reclamant une contraception orale.]
  265. Examination of contraceptive perceptions and usage among Los Angeles County women.
  266. Excess births in 7 southeastern states as a guide for family planning.
  267. Exchange of experience through a workshop on encouragement, identification and extension of innovations in family planning programs.
  268. Experience in using POPSIM in a family planning simulation experiment.
  269. An Experience of a case with Uterovesical Fistula and Foreign-body Stone in Urinary Bladder which formed from Perforation of Uterus and Urinary Bladder with Intra-Uterine Contraceptive Device.
  270. The experience of visitors to family planning clinics in Shiraz, Iran: contraceptive practice, side effects and rumors.
  271. Experience with a new low dose oral contraceptive: norgestimate and ethinyl estradiol.
  272. Experience with contraceptive methods in developed countries.
  273. Experience with contraceptive methods in less developed countries.
  274. An experiment in community involvement in family planning in a metropolitan slum.
  275. Experimentation in family planning delivery systems: an overview.
  276. An extended expectancy-value approach to contraceptive alternatives.
  277. Extrauterine pregnancy and intrauterine contraception. [Ekstrauterin graviditet og intrauterin antikonception.]
  278. Fabrication and testing of vaginal contraceptive devices designed for release of prespecified dose levels of steroids.
  279. Factors affecting family planning services to non-English-speaking immigrants.
  280. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
  281. The facts about a controversial contraceptive.
  282. Failure of withdrawal bleeding during combined oral contraceptive therapy: amenorrhoea on the pill.
  283. Family allowance and family planning in Chile.
  284. Family intentions, family planning, and births. [Familieintensjoner, familieplanlegging of foedsler.]
  285. Family planning - where and how?
  286. Family planning acceptance in Serpong.
  287. Family planning achievement during fiscal year 1978.
  288. Family planning and compulsory ligation.
  289. Family planning and family health.
  290. Family planning and integration.
  291. Family planning and population policies in the Middle East and North Africa.
  292. Family planning and the banjars of Bali.
  293. Family planning and the diabetic mother.
  294. Family planning and the law. 2nd ed.
  295. Family planning and the private primary care physician.
  296. Family planning and the teenager: A service delivery assessment; national report November 1978.
  297. Family planning at Brazilian War College.
  298. Family planning availability and contraceptive practice.
  299. Family planning based on periodic abstinence. A preliminary glossary (draft)
  300. Family planning behavior: a comparative study of foster parents plan clients and non-foster parents plan clients in Yogyakarta. [Perilaku keluarga berencana: sebuah studi perbandingan kelompok pkak dan non-pkak di Yogyakarta.]
  301. Family planning clinic dropouts.
  302. Family planning costs. (Letter)
  303. Family planning course for nurses and midwives in the Philippines.
  304. Family planning education as an integral part of day care services in Korea.
  305. The family planning extra drive in East Java.
  306. The family planning factor.
  307. Family planning for immigrants inhibited by cultural factors.
  308. Family planning in Africa - an overview. (Statement, April 26, 1978)
  309. Family planning in big town conditions depending on the birthplace of the parents.
  310. Family planning in Boston: Boston project succeeds as one of few Massachusetts service and education providers.
  311. Family planning in Brazil. [Planejamento familiar no Brasil.]
  312. Family planning in China.
  313. (Family planning in Egypt.) (Statement, April 26, 1978.)
  314. Family planning in four Latin American countries: knowledge, use and unmet need: some findings from the World Fertility Survey.
  315. Family planning in India: living with frustration.
  316. Family planning in Japan: a comparison between successful and unsuccessful couples.
  317. Family planning in Jutung County, China.
  318. Family planning in Kenya.
  319. Family planning in Labor Welfare Center: a baseline K.A.P. survey.
  320. Family Planning in Pakistan 1955-1977: a review.
  321. Family planning in rural America: innovations, obstacles and service delivery systems. (Abstract only)
  322. Family planning in Sri Lanka: A family life survey in two ethnically different areas; report No. 1.
  323. Family planning in the context of integrated rural development--BRAC.
  324. Family planning information and motivation by voluntary groups at grass-root level: mothers' clubs.
  325. Family planning knowledge, attitudes, and practice of women in Bohol.
  326. Family planning manual for midwives. [Manual de planeamento familiar para parteiras.]
  327. Family planning methods and contraceptive distribution systems in family planning programs. [La planeacion de existencias y la distribucion de anticonceptivos en los programas de planificacion familiar.]
  328. Family planning methods of contraception.
  329. Family Planning Module. [Module sur la planification familiale.]
  330. Family planning mothers' club in Korea.
  331. Family planning nursing in Britain.
  332. Family planning of Portuguese immigrants and integration in Belgium.
  333. Family planning opinion leadership in the United States.
  334. Family planning performance in India: district level analysis.
  335. Family planning personnel.
  336. Family planning practice among primary school teachers and their perception of children.
  337. Family planning program as being carried by CEOSS for the period from January 78 till March 78.
  338. Family planning program Bangladesh.
  339. Family planning program costs. [Costos de programas de planificacion familiar.]
  340. Family planning program effectiveness study.
  341. The family planning program in Indonesia.
  342. The family planning programme: achievements and prospects.
  343. Family planning programs found to be a major factor behind sharp fertility declines in Latin America and Asia.
  344. Family planning provisions and attitudes: a survey in three Hong Kong public housing estates.
  345. (Family planning services for adolescents.) (Statement, March 1, 1978)
  346. Family planning services for indigent women and girls.
  347. Family planning services in the home. (Abstract only)
  348. Family planning services provided by obstetrician-gynecologists in private practice, California, 1975.
  349. The family planning services: changes and effects.
  350. Family planning training: a network program and sample instructional materials.
  351. Family planning under the emergency: policy implications of incentives and disincentives.
  352. Family planning, contraception, voluntary sterilization and abortion: an analysis of laws and policies in the United States, each state and jurisdiction (as of October 1, 1976 with 1978 addenda)
  353. Family planning, fertility decline, and family size preference in Hong Kong: some general observations.
  354. Family Planning.
  355. Family planning.
  356. Family planning.
  357. Family planning. 10. A module in population education for teachers. Rev. ed.
  358. Family Planning/Health and Hygiene Project: a report on the baseline survey.
  359. Family planning: everyone's right, each one's duty. (Statement, April 25, 1978)
  360. Family planning: sudden infant death syndrome bills.
  361. FDA assailed for not approving Depo-Provera for contraception.
  362. FDA denies approval of Depo-Provera in U.S. for contraception; risks outweigh benefits.
  363. FDA said to withhold some data on contraceptives.
  364. Fecundability and contraceptive opportunities.
  365. Female fertility and family planning in Trinidad and Tobago.
  366. Fertility after oral contraception. [Fertilite apres contraception orale.]
  367. Fertility after stopping different methods of contraception.
  368. Fertility and contraception in America: adolescent and pre-adolescent pregnancy. (Witnesses)
  369. Fertility and contraception in America: contraceptive technology and development. (Witnesses)
  370. Fertility and contraception in America: domestic fertility trends and family planning services. (Introduction and discussion))
  371. Fertility and family planning in Atteridgeville: data for 1969, 1974 and 1975.
  372. Fertility and family planning in Buenos Aires, Rio de Janeiro, and Caracas.
  373. Fertility and family planning in Chatsworth: data for 1969, 1975 and 1977.
  374. Fertility and family planning in rural Northern Thailand.
  375. Fertility awareness and the ovulation method: natural birth control.
  376. Fertility control and family planning in the United States of America. [Control de fecundidad y planificacion de la familia en Estados Unidos de America.]
  377. Fertility control and income distribution in developing countries with national family planning programmes.
  378. Fertility decline and birth control in the People's Republic of China.
  379. Fertility effects of family planning programs: a methodological review.
  380. Fertility levels and contraceptive practices among central government employees in India.
  381. Fertility, mortality, migration and family planning in the Yemen Arab Republic.
  382. Fibrocystic breast disease in oral-contraceptive users: a histopathological evaluation of epithelial atypia.
  383. A field study of the choice and continuity of use of 3 contraceptive methods in a rural area of Thailand.
  384. First Asian Workshop on Injectable Contraceptives.
  385. The first international conference on the regulation of birth and the ovulation method of natural family planning (Editorial)
  386. Five days of study and accounting on contraception. [Cinquiemes journees d'etude et de bilan sur la contraception.]
  387. Focal nodular hyperplasia of the liver and contraceptive steroids.
  388. Focal nodular hyperplasia of the liver and oral contraceptives.
  389. Focal nodular hyperplasia of the liver and oral contraceptives. [Fokale nodulare Hyperplasie der Leber und orale Kontrazeptiva.]
  390. Follow-up during oral contraception.
  391. Follow-up of APCO IV and future direction of the Integrated Family Planning, Nutrition and Parasite Control Program.
  392. Formulation-dependent effect of oral contraceptives on H.D.L.-cholesterol. (Letter)
  393. The fourth progress report on the integrated project of family planning, parasite control and nutrition in Sawahlunto, West Sumatra and Serpong, West Java, Indonesia.
  394. FPAI (Family Planning Association of India) holds its biennial general meeting.
  395. A fresh look at family planning communication.
  396. From abortion to contraception: the Japanese experience.
  397. From one generation to the next: changes in fertility, family size preferences, and family planning in an Indian state between 1951 and 1975.
  398. Fundamental ethical and legal concepts in preventive sterilization for contraceptive purposes. [Fondements ethieques et juridiques de la sterilization preventive a but anti-conceptionnel.]
  399. Funding for natural family planning providers.

     

  400. Further comments on contraceptive hormones and congenital heart disease.
  401. Further study on the effect of norethisterone enanthate, an injectable contraceptive on body functions.
  402. The future of natural family planning.
  403. Gall bladder disorders in women under oral contraceptive drugs: personal statistics. [Troubles vesiculaires au cours de la contraception orale: statistique personelle.]
  404. Gas-liquid chromatographic analysis of lynestrenol in contraceptive tablets.
  405. General practical implications for family planning programmes and research: summary.
  406. General review: liver and oral contraceptives. [Foie et contraceptifs oraux.]
  407. Genital actinomycosis and intrauterine contraceptive devices: cytopathological diagnosis and clinical significance.
  408. Glossary of terms in family planning.
  409. Gonadotropin and prolactin secretion during hormonal contraception.
  410. (Government involvement in family planning services: positive results from the Illinois Family Planning Council, Inc.) (Statement, February 22, 1978)
  411. (Government involvement in family planning: negative aspects.) (Statement, February 22, 1978)8.
  412. Government's role in family planning. (Statement, February 22, 1978)
  413. Guide for activities in the voluntary promotion of family planning. [Guia para las actividades del promotor voluntario de planificacion familiar.]
  414. A guidebook for family planning education.
  415. Gynecology in childhood and adolescence. 2. Surgical interventions, contraception for adolescents, legal questions. [Gynaekologie im Kindes- und Jugendalter. 2. Chirugische Eingriffe, Anitkonzeption bei Jugendlichen, Rechtsfragen.]
  416. H.D.L. cholesterol during oral contraception.
  417. Hair analysis of trace minerals in human subjects as influenced by age, sex and contraceptive drugs.
  418. Haitian government and private centre cooperate to provide family planning services and education.
  419. Happy Family Organization: role in family planning activities.
  420. Headache and oral contraceptives (author's transl) [Cefaleia e contraceptivos orais.]
  421. Health and family planning.
  422. Health benefits of voluntary family planning.
  423. Health care, family planning, and environmental protection: foreign assistance programmes. (United States of America)
  424. Health service research in family planning.
  425. Health systems' offerings in family planning and contraception in 3 Oestfold districts. [Helsevesenets tilbud i familieplanlegging og prevensjon i tre Oestfold-kommuner.]
  426. Heating of metallic intrauterine contraceptive devices during ultrasound examination.
  427. Hemostatic changes induced by exercise during oral contraceptive use.
  428. Hepatic tumors and oral contraceptives.
  429. Hepatocarcinoma and oral contraceptives. (Letter)
  430. Hepatocellular carcinoma associated with oral contraceptives.
  431. Hepatocellular carcinoma in a young woman with prolonged exposure to oral contraceptives.
  432. Hepatocellular carcinoma in young women on oral contraceptives. (Letter)
  433. Hepatocellular carcinoma possibly induced by oral contraceptives.
  434. Herpesvirus hominis endometritis in a young woman wearing an intrauterine contraceptive device.
  435. The historical development and expansion of family planning in Asia. (Statement, April 27, 1978)
  436. A historical understanding of contraception.
  437. History (of oral contraceptives)
  438. A history of family planning in Sri Lanka.
  439. Homocystinuria and oral contraceptives. (Letter)
  440. The hormonal basis of discontinuous progestational contraception. [Bases hormonales de la contraception progestative discontinue.]
  441. Hormonal content of plasma and endometrium of women taking oral contraceptives.
  442. Hormonal contraception for adolescents? (author's transl) [Hormonale Kontrazeption bei Jugendlichen?]
  443. Hormonal contraception for men.
  444. Hormonal contraception using the oral depot preparation, Deposiston. [Khormonalna kontratseptsiia s pomoshtta na oralen depo-preparat Deposiston.]
  445. Hormonal contraceptives in fertility control programs.
  446. Hormonal steroid contraceptives: a further review of adverse reactions.
  447. Hormone contraceptives: an overview.
  448. A hormone-cytological study of the oral mucous membrane in females taking regularly oral contraceptives. [Fogamzasgatlo tablettat szedo nok szajnyalkahartyajanak hormoncitologiai vizsgalata.]
  449. How family planning succeeded in Singapore.
  450. How to distinguish 2-phase (sequential) steroid contraceptives. [Jak rozlisovat dvoufazova (sekvencni) steroidni kontraceptiva.]
  451. How to remove the barriers of family planning programme in Bangladesh.
  452. Howrah (India): community-based distribution of contraceptives.
  453. Humanae Vitae commemorations recognize natural family planning research.
  454. Hyperlipidemia aggravated or induced by combined oral contraceptives: preliminary results of a decision-making scheme for the prevention of cardiovascular episodes. [Hyperlipidemies revelees ou induites par les contraceptifs estroprogestatifs. Attitudes adoptees--resultats preliminaires.]
  455. Hyperplastic changes and oral contraceptives in Anglo-Saxon countries. [Zmiany rozrostowe i doustna antykoncepcja sterydowa w krajach anglosaskich.]
  456. Hypertension and nephropathia during pregnancy and while using oral contraceptives. [Hypertonie und Nephropathie waehrend der Schwangerschaft und unter Einnahme von Ovulationshemmern.]
  457. Hypertension and oral contraceptives.
  458. Hypertension and oral contraceptives. (Letter)
  459. Hypertension and oral contraceptives. (Letter)
  460. Hypertension and oral contraceptives. [Hypertoni och p-piller.]
  461. Hypertension due to hormonal contraceptives and estrogens (author's transl) [Hypertonie durch hormonale Kontrazeptiva und Oestrogene.]
  462. Hypovitaminosis B6 and oral contraception. [P-piller og vitamin B6.]
  463. The ideal vaginal barrier contraceptive. (Staff memorandum)
  464. Identification of ejaculate derived propylamine found in collagen sponge contraceptives.
  465. IE&C for family planning in Tunisia: the ONPFP program.
  466. IGG and IGM under short-term and long-term administration of different hormonal contraceptives. [Zum Verhalten der Serumimmunglobulin-Titer von IgA, IgG und IgM bei Kurz- und Langzeitapplikation verschiedener hormonaler Kontrazeptiva.]
  467. Immediate post-termination contraception insertion of copper T device following menstrual aspiration.
  468. Immediate postabortal contraception with a microdose combined preparation: gonadotropin, estradiol and progesterone levels during the last treatment cycle and after discontinuation of oral contraceptives.
  469. Immediate postabortal contraception with a microdose combined preparation: suppression of pituitary and ovarian function and elimination of HCG.
  470. The impact of community and program-level factors on the fertility and contraceptive behaviour of women in Pakistan.
  471. Impact of family planning information on acceptance at a Ghanaian rural health post.
  472. The impact of family planning programme on school education: a study.
  473. The impact of natural family planning in six dioceses in Tamil Nadu: a study.
  474. Impact of the Malaysian family planning programme on births: a comparison of matched acceptor and non-acceptor birth rates.
  475. Impact of the official program of family planning and fertility in Costa Rica, 1960-1982: preliminary study. [Impacto del programa oficial de planificacion familiar en la fecundidad, Costa Rica, 1960-1982: estudio preliminar.]
  476. The implementation gap: theory vs. practice in family planning in Mexico.
  477. Implementing family planning in a Ministry of Health: organizational barriers at the state and district levels.
  478. Implications of oral contraceptive use on vitamin nutritional status.
  479. Implications of the World Fertility Survey for family planning and population education programs.
  480. Importance of correct identification of intrauterine contraceptive device. (Letter)
  481. Importance of research in reproductive biology and contraceptive development: comments concerning the National Institute for Child Health and Development.
  482. Improving family planning services for teenagers.
  483. Improving management through evaluation: techniques and strategies for family planning programs.
  484. Inactivation of clinical isolates of Herpesvirus hominis, types 1 and 2, by chemical contraceptives.
  485. An incentive scheme for family planning: the special integrated financing program of the rural bank of San Luis, Pampanga.
  486. Incidence of depressive symptoms in users of the oral contraceptive.
  487. Incidence of mycotic vaginitis in women using oral contraceptives. [Czestosc wystepowania drozdzycy pochwy u pacjentek stosujacych antykoncepcje doustna.]
  488. The incidence of psychological complications after contraceptive sterilization.
  489. Incidence of spontaneous abortion with and without previous use of contraceptive agents based on morphological studies. [Haeufigkeit von Spontanaborten mit und ohne vorherige Einnahme von Ovulationshemmern anhand morphologischer Untersuchungen.]
  490. Incidence of thyroid disease associated with oral contraceptives.
  491. Increased aldosterone plasma protein binding in women on combined oral contraceptives throughout the menstrual cycle.
  492. India's compulsory sterilization laws: the human right of family planning.
  493. Indications for mechanical contraception. [La contraception mechanique: methodes et indications.]
  494. Indigenous paramedical personnel in family planning in rural Durango, Mexico.
  495. The Indonesia Family Planning Program: basic strategies.
  496. The Indonesia family planning program: basic strategies.
  497. (The Indonesian family planning program.) (Statement, April 27, 1978.)
  498. The Indonesian family planning program: its strategy for the future.
  499. Inefficiency of high doses of urokinase in a massive pulmonary embolism: possible role of an oral contraceptive (Letter) [Inefficacite des fortes doses d'urokinase au cours d'une embolie pulmonaire massive: role possible d'un traitement contraceptif oral.]
  500. The influence of age, sex, and the use of oral contraceptives on the inhibitory effects of endothelial cells and PGI2 (Prostacyclin) on platelet function.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.